Vitrolife AB (publ) is a medical technology firm focused on the development, production, and commercialization of a wide array of products for assisted reproductive procedures. Its extensive product range encompasses specialized instruments such as oocyte retrieval needles and micromanipulation pipettes, alongside crucial consumables like sperm processing solutions, IVF culture media and oil, general labware, incubators, cryopreservation materials, and offerings for preimplantation genetic testing. Furthermore, the company supplies sophisticated technological platforms, including the EmbryoScope and Primo Vision time-lapse embryo monitoring systems, complete with compatible dishes and analytical tools. Other advanced solutions include Octax laser and imaging systems, as well as environmental control devices like log and guard systems and wireless sensors. Vitrolife maintains a significant global presence, with operations spanning Europe, the Middle East, Africa, Asia, the Japan and Pacific regions, and both North and South America. The company, headquartered in Gothenburg, Sweden, was established in 1994, originally operating under the name Scandinavian IVF Science before adopting its current identity as Vitrolife AB (publ) in 1998.
Subscribe to see Vitrolife’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vitrolife is a medical devices company headquartered in Sweden. It is publicly listed (0YAY) with a market capitalisation of $1.2B. Xcout tracks 3 named people at Vitrolife, including Dennis P Wolf (Director).
A few of Vitrolife's closest competitors — see the full list of competitors and alternatives →
Kitazato Corporation is a Japanese entity primarily focused on the research, development, production, and distribution of specialized medical devices and related supplies used in fertility treatment. Headquartered in Shizuoka, Japan, the company offers a comprehensive suite of products catering to reproductive medicine, including precision needles, catheters, and cannulas. Their offerings also extend to advanced vitrification media and equipment, sperm processing media and tools, in-vitro fertilization (IVF) culture media, microsurgical instruments, and various essential labware products. Founded in 1998, the firm was formerly known as Kitazato Biopharma Co., Ltd. Kitazato Corporation operates as a subsidiary under Kitasato Shoji Co., Ltd.
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.
The Cooper Companies, Inc. is a global medical-device company with two main businesses: CooperVision, which develops and sells contact lenses, and CooperSurgical, which provides products and services for women’s health, fertility, and obstetric care. It serves eye-care professionals, patients, and healthcare providers worldwide.
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
AcouSort AB is a Swedish medtech company developing acoustic microfluidic technology for separating and handling cells and other particles in biological samples. Its systems and components are intended for research, diagnostics, and pharmaceutical applications, serving laboratories, diagnostic developers, and life-science companies.
AVE Science&Technology CO.,LTD operates comprehensively in the medical technology sector, engaging in the full spectrum of activities from initial research and development to manufacturing, sales, and post-sale support. Its diverse portfolio includes medical devices, biological reagents, remote medical diagnostic networks, specialized computer software, automated control systems, and various medical auxiliary equipment. The company's product offerings prominently feature advanced diagnostic instruments, such as analyzers for urine formed elements (along with their associated reagents), automated urine analysis systems, multi-functional microscopy devices, semi-automatic biochemical analyzers, and feces analyzers. Complementing these devices, AVE Science&Technology also supplies essential consumables, including reagent kits, quality control solutions for analyzers, test strips, and cleaning agents. Serving a global clientele, the company's reach extends across Europe, the United States, Asia, and Africa. Established in 2000, AVE Science&Technology CO.,LTD is headquartered in Changsha, China. The organization transitioned to its present name in September 2012, having previously been known as Changsha High - tech Industrial Development Zone Aiwei Technology Industrial Co., Ltd.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.